The goal of this clinical trial is to learn if a Artificial Intelligence integrated Mixed Reality-based High-Alert Medications Management Simulation Program (AIMR-HAM) helps hospital nurses manage high-alert medicines (HAMs) more safely. MR mixes real and virtual elements to let nurses practice in realistic scenarios.
The main questions are:
Does the AIMR-HAM improve nurses' medication safety skills? Does the AIMR-HAM lower medication errors and improve clinical performance?
Researchers will compare two groups to answer these questions:
Intervention group: AIMR-HAM Control group: standard education only
Who can take part:
Nurses who work at large hospitals and have 1 to 6 years of clinical experience.
About 60 nurses will join the study.
What participants will do:
Attend the assigned training (AIMR-HAM or standard education only). Complete short tests and surveys before and after training to measure skills, communication, and clinical reasoning.
Report any medication errors that occur during the study. Why this matters: The study will show whether AIMR-HAM training can improve how nurses handle HAMs and make patient care safer.
Nurses with at least one to six years of clinical experience.
Those who understand the purpose and procedures of this study and have given written consent to participate.
Those who have no physical or cognitive limitations in using mixed reality devices.
Those who do not wish to participate in the study. ② Those who have participated in education related to high-alert medications within the past six months.
Those who are unable or have difficulty participating in the mixed reality education program due to visual, hearing, or neurological impairments, or adverse effects such as dizziness or motion sickness.
Those who voluntarily withdraw from the study midway through.